{"name":"Aegera Therapeutics","slug":"aegera-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBxZmM3Xzktd0pwVS1ieWNGVWxGaVBrLVB2a0FHT2JwVmN4UW8wbHlTeDI1bUZIOWY2WmlKaFNqWkxrSjdlTlJUdHlEWjZQc0huellqUnZkazY3VnJIejhz?oc=5","date":"2020-09-01","type":"pipeline","source":"nature.com","summary":"Breaking through: a new approach to fighting Alzheimer’s disease - nature.com","headline":"Breaking through: a new approach to fighting Alzheimer’s disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE5SVlZQZElscDR3SUotV2xGRU5zdXRUWGNDMkljUXhNam9kQnV0bHgwOEJ5aGFDTktBS3FLMmVPMlIxR1lWYlJHRFFnMHNHSU9LQ2x2akRYekVOdDNkLXZfQ0t2T3Jvdw?oc=5","date":"2017-04-04","type":"deal","source":"Venture Capital Journal","summary":"Richard Glickman, Jacki Jenuth tapped as Lumira Capital partners - Venture Capital Journal","headline":"Richard Glickman, Jacki Jenuth tapped as Lumira Capital partners","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNZi1KNDY2cERDYzk2em9INENEaGJoQngxb3I1QURDdUtQOWpWQk54RU5wTDJpbWloX2FlWnN4RU1BWDUxMllZVmswbnhDVmRLTjJEcE5xR1lVWV85cC1sRnNqb2t6eDg2NVdPNXBqMUZQR25odGJlWTc2QjBUYUJqajM2dTVvTDVsdnV4cUljcU5BbjJh?oc=5","date":"2015-03-20","type":"deal","source":"PMLiVE","summary":"Lilly inks $690m deal with Hanmi for autoimmune drug - PMLiVE","headline":"Lilly inks $690m deal with Hanmi for autoimmune drug","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}